Ceren Ergorul, PhD
About Ceren Ergorul, PhD
Ceren Ergorul, PhD, is the Director of Nonclinical Safety Evaluation at Alkermes in Waltham, Massachusetts. She has extensive experience in nonclinical safety evaluation and has held various roles in the field over the past decade.
Current Role at Alkermes
Ceren Ergorul, PhD, serves as the Director of Nonclinical Safety Evaluation at Alkermes in Waltham, Massachusetts, United States. In this role, she leads the nonclinical safety evaluation efforts, overseeing preclinical safety assessments for drug candidates. Building on her extensive experience, she ensures that safety protocols meet regulatory standards and supports the development of safe and effective therapies.
Previous Experience at Rubius Therapeutics
Ceren Ergorul worked as the Director of Preclinical Development at Rubius Therapeutics for a period of 7 months from 2019 to 2020 in Cambridge, Massachusetts. During her tenure, she contributed to early-stage research efforts, focusing on the preclinical development of therapeutic candidates. Her role involved designing and managing preclinical studies to evaluate the efficacy and safety of new therapies.
Prior Roles at Alkermes and Ironwood Pharmaceuticals
Prior to her current position, Ceren Ergorul served as Principal Scientist in Nonclinical Safety Evaluation at Alkermes from 2016 to 2019, and as Senior Toxicologist at Ironwood Pharmaceuticals from 2014 to 2016. At Alkermes, she was responsible for developing and implementing nonclinical safety strategies. At Ironwood Pharmaceuticals, her role focused on assessing the safety of new drug candidates, ensuring they met rigorous safety standards before progressing to clinical development.
Early Career and Experience at Toxikon Corporation and Harvard Medical School
Ceren Ergorul began her career as a Study Director at Toxikon Corporation from 2010 to 2014, where she oversaw toxicology studies for various clients, helping to ensure the safety and efficacy of pharmaceuticals. Earlier, from 2006 to 2009, she conducted postdoctoral research at Harvard Medical School - Massachusetts Eye and Ear Infirmary, focusing on advanced medical research.
Educational Background
Ceren Ergorul holds a Ph.D. from Boston University, achieved between 1998 and 2006. She earned an M.S. from Boğaziçi University from 1996 to 1998, and a B.S. from Istanbul University, Cerrahpaşa School of Medicine, from 1992 to 1996. Her comprehensive academic background in medical and scientific research laid the foundation for her extensive career in nonclinical safety evaluation and toxicology.